@whozat
Options are usually offered as an incentive to participate in a CR. My point is that a lot of options can sometimes be just as damaging or even more damaging than dilution from a CR to some holders. It may not be in the best interest of some people; those that bought on market and especially directors that hold a different type of option that expire in 2023. Exercising FGROC to those mentioned will likely dilute their shares with little gain.
Again, just a though experiment.
FGR - USA Research report, page-18
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
